Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | OBI-992 |
Trade Name | |
Synonyms | OBI992|OBI 992|BSI 992|BSI-992|BSI992 |
Drug Descriptions |
OBI-992 is an antibody-drug conjugate (ADC) comprising an antibody that targets TACSTD2 (TROP2) linked to a topoisomerase I inhibitor, which may induce cytotoxicity against TROP2-expressing tumor cells and inhibit tumor growth (Cancer Res (2024) 84 (6_Supplement): 1893). |
DrugClasses | TROP2 Antibody 13 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
OBI-992 | OBI-992 | 0 | 1 |